We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

45 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 16

6% more capital invested

Capital invested by funds: $38.3M → $40.7M (+$2.32M)

0.28% less ownership

Funds ownership: 11.52% → 11.24% (-0.28%)

10% less funds holding

Funds holding: 50 → 45 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
45
Holders Change
-5
Holders Change %
-10%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
20
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$769K
2
DA
Doliver Advisors
Texas
+$491K
3
TC
TFS Capital
Pennsylvania
+$407K
4
NIM
Needham Investment Management
New York
+$403K
5
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
+$317K

Top Sellers

Rank Fund Capital Flow
1
AAM
Advisors Asset Management
Colorado
-$880K
2
Wells Fargo
Wells Fargo
California
-$692K
3
CCP
Clough Capital Partners
Massachusetts
-$532K
4
Morgan Stanley
Morgan Stanley
New York
-$291K
5
UBS Group
UBS Group
Switzerland
-$287K
Name Holding Trade Value Shares
Change 		Change in
Stake
NEPWA
26
New England Private Wealth Advisors
Massachusetts
$224K – – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$219K -$35.3K -1,873 -14%
MIC
28
Meridian Investment Counsel
California
$191K – – –
Creative Planning
29
Creative Planning
Kansas
$176K +$13.5K +714 +8%
IA
30
IFP Advisors
Florida
$175K +$58.5K +3,106 +50%
MFS
31
MSI Financial Services
Massachusetts
$108K -$59.8K -3,173 -36%
VNA
32
Valley National Advisers
Pennsylvania
$59K -$1.7K -90 -3%
ASN
33
Advisory Services Network
Georgia
$43K +$17.2K +910 +65%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$32K -$2.83K -150 -8%
NFG
35
Next Financial Group
Texas
$30K +$12.4K +660 +71%
NSIM
36
North Star Investment Management
Illinois
$23K +$961 +51 +4%
AWM
37
AllSquare Wealth Management
New York
$19K +$18.8K +1,000 New
SIA
38
SeaBridge Investment Advisors
New Jersey
$18K – – –
MSFP
39
Mark Sheptoff Financial Planning
Connecticut
$13K – – –
BC
40
Barnett & Company
Tennessee
$10K – – –
BAM
41
Bruderman Asset Management
New York
$1K +$38 +2 +6%
TJHA
42
Thomas J. Herzfeld Advisors
Florida
$1K +$38 +2 +3%
US Bancorp
43
US Bancorp
Minnesota
$1K +$1.41K +75 New
CCP
44
Clough Capital Partners
Massachusetts
– -$532K -30,922 Closed
UCFA
45
United Capital Financial Advisors
Texas
– -$185K -10,863 Closed
Invesco
46
Invesco
Georgia
– -$183K -10,629 Closed
WS
47
Wedbush Securities
California
– -$174K -10,104 Closed
Northwestern Mutual Wealth Management
48
Northwestern Mutual Wealth Management
Wisconsin
– -$18K -1,060 Closed
AIM
49
Arcadia Investment Management
Michigan
– -$7K -415 Closed
Deutsche Bank
50
Deutsche Bank
Germany
– -$5K -321 Closed
1
2
3

HQL Hedge Fund Activity: Q3 2016 in Review

45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2016, worth a combined $40.7M — up 6% from $38.3M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of HQL and 3 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 20 added.

The largest buyer was Citigroup, adding an estimated $769K. The largest seller was Advisors Asset Management, cutting an estimated $880K.

  • 45 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2016, down from 50 in Q2 2016.
  • Funds reported $40.7M of abrdn Life Sciences Investors stock for Q3 2016, up 6% quarter-over-quarter.
  • 3 funds opened new abrdn Life Sciences Investors positions in Q3 2016 and 8 closed out, a net change of -5 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2016 was Citigroup, an estimated $769K added.
  • The largest abrdn Life Sciences Investors seller in Q3 2016 was Advisors Asset Management, an estimated $880K sold.

Based on aggregated 13F filings for Q3 2016.